Table 3 Demographic and clinical data of the selected subgroup.

From: Applicability of optical coherence tomography angiography (OCTA) imaging in Parkinson’s disease

 

PD group (42 eyes)

Control group (53 eyes)

p

Age (years)

69.67 ± 9.16 (51–86)

69.61 ± 9.55 (48–83)

0.982

Gender (F/M)

14/14

14/15

0.898

MAP (mmHg)

94.79 ± 6.72

95.96 ± 7.59

0.551

Disease duration (years)

9.74 ± 6.15 (1–24)

N/A

–

Hoehn and Yahr scale

1.47 ± 0.90

0.0 ± 0.0

–

MDS-UPDRS-III score (ON)

24.32 ± 10.95

2.57 ± 3.24

–

BCVA (logMAR)

0.03 ± 0.06

0.03 ± 0.05

0.955

IOP (mmHg)

15.42 ± 2.90

16.57 ± 3.04

0.078

AL (mm)

23.65 ± 1.66

23.96 ± 0.93

0.510

  1. AL axial length, BCVA best-corrected visual acuity, F female, IOP intraocular pressure, logMAR logarithm of the minimal angle of resolution, M male, N/A not applicable, MDS-UPDRS Movement Disorder Society Unified Parkinson's Disease Rating Scale; Results are reported as mean ± standard deviation (range). p < 0.05 was considered statistically significant.
Back to article page